Tudor Investment Corporation »

Aeglea Biotherapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $916k 31k 29.41